Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Illumina, Inc.
  6. Summary
    ILMN   US4523271090

ILLUMINA, INC.

(ILMN)
  Report
Delayed Nasdaq  -  04:00:00 2023-05-30 pm EDT
194.51 USD   -0.70%
05/25Illumina, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/25Sector Update: Health Care Stocks Falling Late Thursday
MT
05/25Sector Update: Health Care
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/23/2023 05/24/2023 05/25/2023 05/26/2023 05/30/2023 Date
204.37(c) 212.65(c) 193.53(c) 195.89(c) 194.51(c) Last
753 912 1 987 922 3 777 572 1 782 677 1 320 769 Volume
-2.15% +4.05% -8.99% +1.22% -0.70% Change
More quotes
Estimated financial data (e) (USD)
Sales 2023 4 931 M - -
Net income 2023 45,1 M - -
Net Debt 2023 289 M - -
P/E ratio 2023 384x
Yield 2023 -
Sales 2024 5 720 M - -
Net income 2024 424 M - -
Net cash position 2024 1 217 M - -
P/E ratio 2024 69,8x
Yield 2024 -
Capitalization 30 752 M 30 752 M -
EV / Sales 2023 6,29x
EV / Sales 2024 5,16x
Nbr of Employees 11 530
Free-Float 79,1%
More Financials
Company
llumina, Inc. est spécialisé dans le développement, la fabrication et la commercialisation de systèmes intégrés dédiés à l'analyse de la variation génétique et de la fonction biologique. Les produits du groupe sont destinés aux centres de recherche génomique, aux sociétés pharmaceutiques, aux institutions universitaires, aux organisations de recherche clinique et aux sociétés de biotechnologies. Le CA par source de... 
Read more
More about the company
Ratings of Illumina, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about ILLUMINA, INC.
05/25Illumina, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/25Sector Update: Health Care Stocks Falling Late Thursday
MT
05/25Sector Update: Health Care
MT
05/25Illumina Elects Icahn Nominee to Board, Ousts Chairman John Thompson; Shares Tumble
MT
05/25Illumina Board Elects Eight of Nine Director Nominees Including Icahn Nominee Andrew Te..
MT
05/25Illumina announces preliminary results of annual meeting
PR
05/25Illumina Announces Preliminary Results of Annual Meeting
CI
05/25Illumina, Inc. Announces Board Changes
CI
05/25Sector Update: Health Care Stocks Dropping in Afternoon Trading
MT
05/25Icahn wins one board seat at Illumina
RE
05/25Sector Update: Health Care
MT
05/25Nvidia sparks AI rally
MS
05/25Carl Icahn to Reportedly Obtain Enough Support for at Least One Seat on Illumina's Boar..
MT
05/24Exclusive-Icahn poised to win at least one seat on Illumina's board -sources
RE
05/24Carl icahn set to win enough illumina inc shareholder…
RE
More news
News in other languages on ILLUMINA, INC.
08:42pLe PDG d'Illumina a survécu à la contestation d'Icahn avec une marge de plus de 2 contr..
05/26Les valeurs à suivre à Wall Street - Vendredi 26 mai 2023
05/26Illumina: demi-victoire de l'investisseur activiste Carl Icahn
05/25Mise à jour sectorielle : Les actions du secteur de la santé chu..
05/25Mise à jour sectorielle : Soins de santé
More news
Analyst Recommendations on ILLUMINA, INC.
More recommendations
ETFs positioned on ILLUMINA, INC.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
VanEck Genomics and Healthcare Innovators - USD6.14%-5.33%-NC
BMO MSCI Genomic Innovation Index ETF - CAD4.66%0.00%-NC
VanEck Biotech ETF - USD4.48%-3.77%United_States
Xtrackers MSCI Genomic Healthcare Innovatio...4.2%-4.33%-NC
Global X Telemedicine & Digital Health - USD3.45%-4.30%-NC
More ETFs positioned on ILLUMINA, INC.
Analysis
Icahn wins one board seat at Illumina
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 194,51 $
Average target price 244,34 $
Spread / Average Target 25,6%
EPS Revisions
Managers and Directors
Francis A. deSouza Chief Executive Officer & Director
Joydeep Goswami CFO, Chief Strategy & Development Officer
Phillip G. Febbo Chief Medical Officer
Alex Aravanis CTO, Head-Research & Product Development
Carissa Rollins Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
ILLUMINA, INC.-3.80%30 970
THERMO FISHER SCIENTIFIC-5.21%201 354
DANAHER CORPORATION-12.51%171 347
INTUITIVE SURGICAL, INC.15.66%107 537
BOSTON SCIENTIFIC CORPORATION10.35%73 409
SIEMENS HEALTHINEERS AG14.92%64 380
-40% off: Our subscriptions help you unlock hidden opportunities!
Subscribe
fermer